Lirum Therapeutics, Inc. (LRTX)

Lirum Therapeutics Statistics

Total Valuation

LRTX has a market cap or net worth of $45.00 million. The enterprise value is $40.99 million.

Market Cap	45.00M
Enterprise Value	40.99M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

LRTX has 9.00 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	9.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 20.45.

PE Ratio	20.45
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	18.83
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	18.63
EV / Sales	n/a
EV / EBITDA	18.57
EV / EBIT	18.57
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	355.84

Financial Efficiency

Return on equity (ROE) is 92.09% and return on invested capital (ROIC) is -91.83%.

Return on Equity (ROE)	92.09%
Return on Assets (ROA)	48.16%
Return on Capital (ROIC)	-91.83%
Revenue Per Employee	n/a
Profits Per Employee	$733,566
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-2.19M
Pretax Income	2.20M
Net Income	2.20M
EBITDA	2.21M
EBIT	2.21M
Earnings Per Share (EPS)	$0.24

Balance Sheet

The company has $4.01 million in cash and no debt, giving a net cash position of $4.01 million or $0.45 per share.

Cash & Cash Equivalents	4.01M
Total Debt	n/a
Net Cash	4.01M
Net Cash Per Share	$0.45
Equity (Book Value)	2.39M
Book Value Per Share	0.27
Working Capital	2.39M

Cash Flow

Operating Cash Flow	-2.24M
Capital Expenditures	n/a
Free Cash Flow	-2.24M
FCF Per Share	-$0.25

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LRTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	4.89%
FCF Yield	-4.98%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2